YennyAlejandraMoreno VanegasMD

PubMed

• 1 citations
  Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma.
  Razan Mohty, Yenny Moreno Vanegas, Julio C Chavez, Mohamed A Kharfan-Dabaja> ;Expert Review of Anticancer Therapy. 2023 Feb 1
• 1 citations
  CAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19.
  Yenny M Vanegas, Razan Mohty, Martha E Gadd, Yan Luo, Mahmoud Aljurf, Hong Qin, Mohamed A Kharfan-Dabaja> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 1 citations
  Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes.
  Yenny Moreno Vanegas, Talha Badar> ;Cancer Management and Research. 2022 Jan 1
• Delayed presentation of doxorubicin extravasation into pleural space: Case report and review of literature.
  Vera Kazakova, Yenny Alejandra Moreno Vanegas, Tyion A Torres, Olga Kozyreva> ;Journal of Oncology Pharmacy Practice. 2021 Aug 1
• Multimodality therapy of endometrial glassy cell carcinoma: a rare type of cancer.
  Vera Kazakova, Yenny Alejandra Moreno Vanegas, Arun Kadamkulam Syriac, Olga Kozyreva> ;BMJ Case Reports. 2020 Jun 1
• 3 citations
  Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features.
  Bhagirathbhai Dholaria, Yenny Alejandra Moreno Vanegas, Nancy N. Diehl, Aaron Spaulding, Sue L. Visscher, Han W. Tun, Sikander Ailawadhi, Prakash Vishnu> ;Clinical Hematology International. 2020 Apr 23
• Join now to see all